Recent News

• 10.30.2025 - Interim Management Statement Q3 2025
• 10.30.2025 - Interim Management Statement Q3 2025
• 08.25.2025 - Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
• 08.25.2025 - Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
• 08.21.2025 - Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
• 08.21.2025 - Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
• 08.05.2025 - Molecular Partners H1 2025 Results
• 08.05.2025 - Molecular Partners H1 2025 Results
• 08.05.2025 - Molecular Partners H1 2025 Results
• 08.05.2025 - Molecular Partners H1 2025 Results

Recent Filings

• 07.17.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 06.25.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 06.12.2025 - EX-99.1 EX-99.1
• 06.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]